RS61256B1 - Piridinil derivati, farmaceutske kompozicije i njihova primena kao aoc3 inhibitori - Google Patents
Piridinil derivati, farmaceutske kompozicije i njihova primena kao aoc3 inhibitoriInfo
- Publication number
- RS61256B1 RS61256B1 RS20201583A RSP20201583A RS61256B1 RS 61256 B1 RS61256 B1 RS 61256B1 RS 20201583 A RS20201583 A RS 20201583A RS P20201583 A RSP20201583 A RS P20201583A RS 61256 B1 RS61256 B1 RS 61256B1
- Authority
- RS
- Serbia
- Prior art keywords
- pharmaceutical compositions
- pyridinyl derivatives
- aoc3 inhibitors
- aoc3
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16169356 | 2016-05-12 | ||
| EP17721706.4A EP3455216B1 (en) | 2016-05-12 | 2017-05-08 | Pyridinyl derivatives, pharmaceutical compositions and uses thereof as aoc3 inhibitors |
| PCT/EP2017/060890 WO2017194453A1 (en) | 2016-05-12 | 2017-05-08 | Pyridinyl derivatives, pharmaceutical compositions and uses thereof as aoc3 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS61256B1 true RS61256B1 (sr) | 2021-01-29 |
Family
ID=55967162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20201583A RS61256B1 (sr) | 2016-05-12 | 2017-05-08 | Piridinil derivati, farmaceutske kompozicije i njihova primena kao aoc3 inhibitori |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US9926292B2 (sr) |
| EP (1) | EP3455216B1 (sr) |
| JP (1) | JP6639702B2 (sr) |
| KR (1) | KR20190003995A (sr) |
| CN (1) | CN109153664B (sr) |
| AR (1) | AR108462A1 (sr) |
| AU (1) | AU2017262707B2 (sr) |
| CA (1) | CA3023805A1 (sr) |
| CL (1) | CL2018003158A1 (sr) |
| CO (1) | CO2018012020A2 (sr) |
| CY (1) | CY1123744T1 (sr) |
| DK (1) | DK3455216T3 (sr) |
| EA (1) | EA037188B1 (sr) |
| ES (1) | ES2844926T3 (sr) |
| HR (1) | HRP20202078T1 (sr) |
| HU (1) | HUE053312T2 (sr) |
| IL (1) | IL262662B (sr) |
| JO (1) | JOP20170115B1 (sr) |
| LT (1) | LT3455216T (sr) |
| MA (1) | MA44965B1 (sr) |
| MX (1) | MX2018013701A (sr) |
| PE (1) | PE20190151A1 (sr) |
| PH (1) | PH12018502376A1 (sr) |
| PL (1) | PL3455216T3 (sr) |
| PT (1) | PT3455216T (sr) |
| RS (1) | RS61256B1 (sr) |
| SA (1) | SA518400393B1 (sr) |
| SG (1) | SG11201809687TA (sr) |
| SI (1) | SI3455216T1 (sr) |
| TW (1) | TWI746551B (sr) |
| UA (1) | UA121930C2 (sr) |
| WO (1) | WO2017194453A1 (sr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019254371A1 (en) | 2018-04-17 | 2020-10-08 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| WO2020083264A1 (zh) * | 2018-10-22 | 2020-04-30 | 广东东阳光药业有限公司 | 胍类衍生物及其用途 |
| KR20210084537A (ko) * | 2018-10-29 | 2021-07-07 | 베링거 인겔하임 인터내셔날 게엠베하 | 피리디닐 설폰아미드 유도체, 약제학적 조성물 및 이의 용도 |
| WO2021083209A1 (en) | 2019-10-29 | 2021-05-06 | Eccogene (Shanghai) Co., Ltd. | Ssao inhibitors and use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19518073A1 (de) * | 1995-05-17 | 1996-11-21 | Hoechst Ag | Substituierte Benzyloxycarbonylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| CA2536954C (en) * | 2003-08-29 | 2012-11-27 | Exelixis, Inc. | C-kit modulators and methods of use |
| CA2575411A1 (en) * | 2004-07-27 | 2006-02-02 | Astellas Pharma Inc. | Thiazole derivatives having vap-1 inhibitory activity |
| PL2479165T3 (pl) * | 2009-09-16 | 2018-05-30 | Astellas Pharma Inc. | Związek glicynowy |
| ES2628850T3 (es) * | 2011-03-15 | 2017-08-04 | Astellas Pharma Inc. | Compuesto de guanidina |
| JP6809464B2 (ja) | 2015-08-06 | 2021-01-06 | 宇部興産株式会社 | 置換グアニジン誘導体 |
-
2017
- 2017-05-08 KR KR1020187035976A patent/KR20190003995A/ko active IP Right Grant
- 2017-05-08 DK DK17721706.4T patent/DK3455216T3/da active
- 2017-05-08 EA EA201892539A patent/EA037188B1/ru not_active IP Right Cessation
- 2017-05-08 AU AU2017262707A patent/AU2017262707B2/en not_active Ceased
- 2017-05-08 LT LTEP17721706.4T patent/LT3455216T/lt unknown
- 2017-05-08 CA CA3023805A patent/CA3023805A1/en active Pending
- 2017-05-08 PE PE2018002340A patent/PE20190151A1/es unknown
- 2017-05-08 RS RS20201583A patent/RS61256B1/sr unknown
- 2017-05-08 WO PCT/EP2017/060890 patent/WO2017194453A1/en unknown
- 2017-05-08 SI SI201730584T patent/SI3455216T1/sl unknown
- 2017-05-08 PT PT177217064T patent/PT3455216T/pt unknown
- 2017-05-08 ES ES17721706T patent/ES2844926T3/es active Active
- 2017-05-08 JP JP2018559351A patent/JP6639702B2/ja active Active
- 2017-05-08 PL PL17721706T patent/PL3455216T3/pl unknown
- 2017-05-08 US US15/588,739 patent/US9926292B2/en active Active
- 2017-05-08 MA MA44965A patent/MA44965B1/fr unknown
- 2017-05-08 CN CN201780027576.9A patent/CN109153664B/zh active Active
- 2017-05-08 UA UAA201812102A patent/UA121930C2/uk unknown
- 2017-05-08 MX MX2018013701A patent/MX2018013701A/es unknown
- 2017-05-08 HU HUE17721706A patent/HUE053312T2/hu unknown
- 2017-05-08 EP EP17721706.4A patent/EP3455216B1/en active Active
- 2017-05-08 SG SG11201809687TA patent/SG11201809687TA/en unknown
- 2017-05-11 AR ARP170101262A patent/AR108462A1/es unknown
- 2017-05-11 JO JOP/2017/0115A patent/JOP20170115B1/ar active
- 2017-05-11 TW TW106115558A patent/TWI746551B/zh not_active IP Right Cessation
-
2018
- 2018-10-29 IL IL262662A patent/IL262662B/en unknown
- 2018-11-06 CO CONC2018/0012020A patent/CO2018012020A2/es unknown
- 2018-11-07 SA SA518400393A patent/SA518400393B1/ar unknown
- 2018-11-08 CL CL2018003158A patent/CL2018003158A1/es unknown
- 2018-11-12 PH PH12018502376A patent/PH12018502376A1/en unknown
-
2020
- 2020-12-30 HR HRP20202078TT patent/HRP20202078T1/hr unknown
-
2021
- 2021-01-19 CY CY20211100039T patent/CY1123744T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282584A (en) | History of quinoline and pharmaceutical preparations containing them | |
| HK1243999A1 (zh) | 新型3-吲哚取代的衍生物、藥物組合物及使用方法 | |
| IL248915A0 (en) | Pyrrolidine-2,5-dione derivatives, preparations containing them and their use for the inhibition of ido1 | |
| IL258082B (en) | History of benzaimidazole and pharmaceutical preparations containing them | |
| IL247062A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical preparations containing them | |
| EP3214090A4 (en) | Thionucleoside derivative or salt thereof, and pharmaceutical composition | |
| HK1231416A1 (zh) | 西羅莫司及其衍生物的絡合物、其製備方法以及含有其的藥物組合物 | |
| IL250422A0 (en) | History of pyrrolidinone, and pharmaceutical preparations containing them | |
| HK1256674A1 (zh) | 氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途 | |
| IL262662B (en) | History of pyridinyl, pharmaceutical preparations and their uses as aoc3 inhibitors | |
| EP3124486A4 (en) | Substituted nitrogen-containing heterocyclic derivatives, pharmaceutical compositions comprising the same and applications of antitumor thereof | |
| IL249308A0 (en) | The history of quinoline, their preparation and pharmaceutical preparations containing them | |
| IL248785B (en) | Antecedents of ]-n5,1-dimethyl3--oxo-(3,2-dihydro-h1-pyrazol-4-yl)]-methyl-isoxazole-3-carboxamide and pharmaceutical preparations including these antecedents | |
| IL258160B (en) | Biaryl derivatives, pharmaceutical preparations containing them and their uses | |
| IL248773B (en) | History -6,1-Naphthyridine-5,4-Dione and pharmaceutical preparations containing them | |
| IL304109A (en) | Pharmaceutical preparations containing spinamide | |
| IL258977B (en) | Pyperidyl derivatives, their preparation and pharmaceutical compositions containing them | |
| IL247220A0 (en) | Amino pyrazoline derivatives, preparations containing them and their uses | |
| IL254711B (en) | History of diazepine-indole and medicinal preparations containing them | |
| IL259900A (en) | Aminoazole derivatives, compositions containing same and uses thereof | |
| HUE058886T2 (hu) | Safinamidot tartalmazó gyógyászati készítmények | |
| ZA201607127B (en) | Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors | |
| EP3326631A4 (en) | PAC-1 COMPOUND OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |